Citi Starts Epizyme (EPZM) at Buy
FREE Breaking News Alerts from StreetInsider.com!
- Tech selloff weighs down Wall Street as bond yields climb
- Baidu slips as Q2 results miss estimates despite growth in AI cloud business
- Nvidia or Sandisk? BofA reveals which stock is under-owned and which is crowded
- Home Depot beats estimates, reaffirms fiscal 2026 guidance
- Citi says positioning risk is shifting from short squeezes to profit-taking
- Tech selloff weighs down Wall Street as bond yields climb
- Francisco Partners to acquire Weave Communications for $650M
- Nvidia or Sandisk? BofA reveals which stock is under-owned and which is crowded
- Goldman Sachs to acquire real estate company LCN for up to $410M
- Klarna Group plc (KLAR) Tops Q2 EPS by 6c, Beats on Revenue; Offers FY26 Revenue Guidance
Wedbush Starts Epizyme (EPZM) at Outperform
June 26, 2013 4:49 PM EDTWedbush initiated coverage on Epizyme (NASDAQ: EPZM) with an Outperform rating and a price target of $37.00.
"Advances in genetically defining sub-sets of cancer patients have identified members of the family of histone methyltransferase (HMT) proteins as key drivers of malignancy. . .... More
Cowen Starts Epizyme (EPZM) at Outperform
June 25, 2013 10:32 AM EDTCowen initiates coverage on Epizyme (NASDAQ: EPZM) with a Outperform.
For an analyst ratings summary and ratings history on Epizyme click here. For more ratings news on Epizyme click here.
Shares of Epizyme closed at $27.55 yesterday, with a 52 week range of $18.60-$30.86.... More
JMP Securities Starts Epizyme (EPZM) at Market Outperform
June 25, 2013 8:46 AM EDTJMP Securities initiates coverage on Epizyme (NASDAQ: EPZM) with a Market Outperform.
For an analyst ratings summary and ratings history on Epizyme click here. For more ratings news on Epizyme click here.
Shares of Epizyme closed at $27.55 yesterday, with a 52 week range of $18.60-$30.86.... More
Leerink Swann Starts Epizyme (EPZM) at Outperform
June 25, 2013 7:50 AM EDTLeerink Swann initiates coverage on Epizyme (NASDAQ: EPZM) with a Outperform. PT $34.00.
For an analyst ratings summary and ratings history on Epizyme click here. For more ratings news on Epizyme click here.
Shares of Epizyme closed at $27.55 yesterday, with a 52 week range of $18.60-$30.86.... More
